Showing results (171-180 of 434) with videos related to

Sort By:
Pageof 44
Clinical and Experimental Hepatology|January 4, 2019
The role of metabolic disorders in the pathogenesis of intrahepatic cholestasis of pregnancyTomasz Menżyk, Martyna Bator, Aleksandra Derra, et al.
Clinical and Experimental Hepatology|January 4, 2019
Omega-3 fatty acid supplementation does not influence liver regeneration in rats after partial hepatectomyMohammad Akbari, Suleyman Utku Celik, Akin Firat Kocaay, et al.
Clinical and Experimental Hepatology|June 1, 2026
Development and internal validation of the SCAN score: a pragmatic bedside tool for early prediction of spontaneous bacterial peritonitis in patients with cirrhosis and ascitesYavuz Özden, Osman Sağlam
Clinical and Experimental Hepatology|June 1, 2026
Campesterol induces apoptosis and inhibits proliferation in HepG2 liver cancer cellsAwais Altaf, Tahir Maqbool, Amber Hassan, et al.
Clinical and Experimental Hepatology|April 23, 2026
Implantation of nasobiliary drainage in treatment of severe episodes of benign recurrent intrahepatic cholestasis (BRIC) in pediatric patientsMaciej Dądalski, Tetiana Wojciechowska, Joanna Ryżko, et al.
Clinical and Experimental Hepatology|April 23, 2026
Potential pharmacotherapy pathways in metabolic dysfunction-associated steatotic liver diseasePaweł Rajewski, Jakub Cieściński, Piotr Rajewski, et al.
Clinical and Experimental Hepatology|April 23, 2026
Effect and prognostic factors of the double plasma molecular adsorption system combined with partial plasma exchange (DPMAS-PPE) in patients with liver failureXudong Liu, Xiaofang Zhao, Chunni Liang, et al.
Clinical and Experimental Hepatology|April 23, 2026
Metabolic dysfunction-associated steatotic liver disease in childrenMalgorzata Pawlowska
Clinical and Experimental Hepatology|April 23, 2026
Does thyroid function disorder play a vital role in the pathogenesis of neonatal cholestasis?Salma Abdel Megeed Nagi, Mai Ibrahim Elashmawy, Mohamed Zaeim Hafez Ahmed, et al.
Clinical and Experimental Hepatology|April 23, 2026
Three-year outcomes under pemafibrate therapy in patients with metabolic dysfunction-associated steatotic liver disease: a long-term observational studySatoshi Shinozaki, Kouichi Miura, Toshiyuki Tahara, et al.
Pageof 44